Jim Datin

Jim Datin

Director/Board Member chez ORASURE TECHNOLOGIES, INC.

Fortune : 538 187 $ au 31/03/2024

61 ans
Health Technology
Finance
Technology Services

Profil

Jim A.
Datin
is currently the Chief Executive Officer & Director at BALX Holdings LLC.
He is also an Independent Director at OraSure Technologies, Inc., a Director at Life Sciences Pennsylvania, a Director at Celerant Consulting, Inc., a Director at the Hepatitis B Foundation, a Co-Managing Director at BioAgilytix Europe GmbH, a Director at The North Carolina Biotechnology Center, and an Operating Partner at GHO Capital Partners LLP (starting in 2023).
In his former roles, Mr. Datin served as the Chief Executive Officer of Golden Land Bhd.
He was also the Chief Executive Officer of TouchPoint Solutions from 2004 to 2005.
He held positions as Chairman at Clarient, Inc. and Laureate Biopharmaceutical Services, Inc. Mr. Datin was the EVP & Managing Director-Life Sciences Group at Safeguard Scientifics, Inc. from 2011 to 2013.
He served as the Director of International Business at Merck KGaA and held director positions at Acelerate, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc., Ventaira Pharmaceuticals, Inc., NuPathe, Inc., Putney, Inc., NovaSom, Inc., Intralinks Holdings, Inc., and Smithkline Beckman Corp.
He was the Group Director-Corporate Business Strategy at GlaxoSmithKline, Inc. from 1999 to 2001.
Mr. Datin was also a Director at the University City Science Center and Safeguard International Management LLC.
He served as a Director of International Business at Baxter Corp.
and was an Independent Director at FSD Pharma, Inc. from 2019 to 2021.
He was a Non-Executive Director at BioAgilytix Labs LLC from 2013 to 2022.
Mr. Datin was the Group President at Dendrite International, Inc. in 2004.
He is also a Member of Ben Franklin Technology Partners.
Mr. Datin received his undergraduate degree from Marshall University in 1985.
He earned an MBA from the University of New Haven in 1995.
He also attended The Wharton School of the University of Pennsylvania for his undergraduate studies.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/03/2024 87 510 ( 0,12% ) 538 187 $ 31/03/2024

Postes actifs de Jim Datin

SociétésPosteDébut
ORASURE TECHNOLOGIES, INC. Director/Board Member 11/08/2019
Hepatitis B Foundation Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member 01/01/2017
Chief Executive Officer -
Chief Executive Officer -
Private Equity Investor 01/03/2023
Tous les postes actifs de Jim Datin

Anciens postes connus de Jim Datin

SociétésPosteFin
Chief Executive Officer 16/06/2022
░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jim Datin

Formation de Jim Datin

Marshall University Undergraduate Degree
University of New Haven Masters Business Admin
The Wharton School of the University of Pennsylvania Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jim Datin

Relations

100 +

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
SAFEGUARD SCIENTIFICS, INC.

Finance

MERCK KGAA

Health Technology

ORASURE TECHNOLOGIES, INC.

Health Technology

GOLDEN LAND

Finance

FSD PHARMA INC.

Health Technology

Entreprise privées26

Technology Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Miscellaneous

Technology Services

Finance

Finance

Commercial Services

Health Technology

Commercial Services

Hepatitis B Foundation

Commercial Services

Health Technology

Commercial Services

Finance

Voir les connexions sociétés